Sept. 15, 2005 — The U.S. Food and Drug Administration (FDA), ImClone Systems, Inc., and Bristol-Myers Squibb Co. have notified healthcare professionals via letter of recommendations for observation ...
May 4, 2007 — A startling 97% of cancer patients treated with cetuximab, matuzumab, or panitumumab have some degree of hypomagnesemia, a prospective clinical trial shows. The drugs targeting the ...
The first step in a identifying the etiology of hypomagnesemia is to evaluate fractional urinary excretion of magnesium, Dr. Agus said. A value greater than 4% indicates renal magnesium wasting; ...
We conducted a prospective feasibility study of magnesium-rich diets in patients 18 years and older with previously untreated ovarian cancer scheduled to receive carboplatin-containing chemotherapy of ...
The MarketWatch News Department was not involved in the creation of this content. Consider monitoring magnesium levels prior to initiation of VOQUEZNA and periodically in patients expected to be on ...
CAMBRIDGE, Mass., June 23, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (SRPT), the leader in precision genetic medicine for rare diseases, today announced that the U.S. Food and Drug ...
Disparities in Stage at Presentation Among Hispanic and Latinx Patients With Non–Small-Cell Lung Cancer in the United States We conducted a prospective feasibility study of magnesium-rich diets in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback